Ningaloo Biosystems GmbH
About us
Ningaloo is building a future where no one is left behind when the next medical breakthrough arrives. We enable scalable and cost-efficient bioproduction of complex biopharmaceuticals, such as multispecific antibodies and viral vectors for gene therapy by using synthetic biology based on optogenetics.
Address
Gottfried-Hagen-Str. 60-62
51105 Köln
Germany
E-mail: h.mueller-hartmann@ningaloo.bio
Phone: +49 22178879967
Internet: ningaloo.bio
Contact person:
Dr Herbert Müller-Hartmann
CEO & co-founder
E-mail: h.mueller-hartmann@ningaloo.bio
Phone: +49 173 7278789
Products & Services
Ningaloo Biosystems creates advanced cybergenetic bioproduction systems to produce next-generation biopharmaceuticals with unprecedented efficiency. With their synthetic biology technology, they realize real-time control to manage host cell lines in the bioreactor process, helping developers and manufacturers enhance the yield and quality of complex biological drugs. Ningaloo runs initial collaborative pilots on a complex protein drug and a gene therapeutic.
Scalable cell-culture illumination hardware and software
We provide precise, scalable light delivery systems compatible with industry-standard cultivation formats. These "plug-on" illumination systems ensure homogeneous light delivery illumination and quantitative transferability of optogenetic signals from small-scale formats (multiwell plates, shake flasks) to larger-scale bioreactors.